- Hunninghake DB, Stein EA, Dujovne CA, Harris WS, Feldman EB, Miller VT, Tobert JA, Laskarzewski PM, Quiter E, Held J, Taylor AM, Hopper S, Leonard SB, Brewer BK. The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia. N Engl J Med 1993;328: 1213–1219.
- Schaefer EJ, Brosseau ME. Diet, lipoproteins, and coronary heart disease. Endocrinol Metab Clin North Am 1998;27: 711–727.
- Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, Ports TA, McLanahan SM, Kirkeeide RL, Brand RJ, Gould KL. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990; 336: 129–133.
- Grundy SM. What is the desirable ratio of saturated, polyunsaturated, and monounsaturated fatty acids in the diet? Am J Clin Nutr 1997;66 (Suppl): 988S–990S.
- Knopp RH. Drug treatment of lipid disorders. N Engl J Med 1999;341: 498–511.
- Keys A, ed. Coronary heart disease in seven countries. American Heart Association monograph 29. Circulation 1970;41 (Suppl 1): 1–211.
- Blackburn H. The low risk coronary male. Am J Cardiol 1986;58: 161.
- Keys A, Anderson JT, Grande F. Serum cholesterol response to changes in the diet, IV: particular saturated fatty acids in the diet. Metabolism 1965; 14: 776–787.
- Renaud S, de Lorgeril M, Delaye J, Guidollet J, Jacquard F, Mamelle N, Martin JL, Monjaur I, Salen P, Toubol P. Cretan Mediterranean diet for prevention of coronary heart disease. Am J Clin Nutr 1995;61 (6 Suppl): 1360S–1367S.
- de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999;99: 779–785.
- Jacobson TA, Schein JR, Williamson A, Ballantyne CM. Maximizing the cost-effectiveness of lipid-lowering therapy. Arch Intern Med 1998; 158: 1977–1989.
- Braunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia: WB Saunders, 1997: 1228–1229.
- Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;337: 230–236.
- Gaziano JM, Buring JE, Breslow JL, Goldhaber SZ, Rosner B, VanDenburgh M, Willett W, Hennekens CH. Moderate alcohol intake, increased levels of high density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med 1993;329: 1829–1834.
- Trichopoulou A, Vasilopoulou E, Liagiou A. Mediterranean diet and coronary heart disease: are antioxidants critical? Nutr Rev 1999;57: 253–255.
- de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL, Monjaud I, Guidollet J, Touboul P, Delaye J. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994; 343: 1454–1459.
- Wood PD, Stefanick ML, Williams, PT, Haskell WL. The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. N Engl J Med 1991;325: 461–466.
- Stefanick ML, Mackey S, Sheehan M, Ellsworth N, Haskell WL, Wood PD. Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol. N Engl J Med 1998;339: 12–20.
- Wood PD, Stefanick ML, Dreon DM, Frey-Hewitt B, Garay SC, Williams PT, Superko HR, Fortmann SP, Albers JJ, Vranizan KM, Ellsworth NM, Terry RB, Haskell L. Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. N Engl J Med 1988;319: 1173–1179.
- Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 1999;83: 25F–29F.
- Miettinen TA, Puska P, Gylling H, Vanhanan H, Vartiainen E. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med 1995;333: 1308–1312.
- Thompson GR. Poor responders to statins: a potential target for stanol esters. European Heart Journal Supplements 1999;1 (Suppl S): S114–S117.
- Grundy SM. Stanol esters as a dietary adjunct to cholesterol-lowering therapies. European Heart Journal Supplements 1999;1 (Suppl S): S132–S138.
- Thompson GR. Plant lipids that lower serum cholesterol. Eur Heart J 1999; 20: 1527–1529.
- Hunninghake DB, Miller VT, LaRosa JC, Kinosian B, Jacobson T, Brown V, James WH, Edelman D, O'Connor RR. Long-term treatment of hypercholesterolemia with dietary fiber. Am J Med 1994;97: 504–508.
- Swain JF, Rouse IL, Curley CB, Sacks FM. Comparison of the effects of oat bran and low-fiber wheat on serum lipoprotein levels and blood pressure. N Engl J Med 1990;322: 147–152.
- Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995;333: 276–282.
- Connor SL, Connor WE. Are fish oils beneficial in the prevention and treatment of coronary artery disease? Am J Clin Nutr 1997;66 (Suppl): 1020S–1031S.
- O'Keefe JH, Harris WS. From Inuit to implementation: omega-3 fatty acids come of age. Mayo Clin Proc 2000;75: 607–614.
- Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetman PM, Elwood PC, Deadman NM. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial. Lancet 1989;2: 757–761.
- Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999;354: 447–455.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 13, 2000 - Issue 4